HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Azathioprine versus betamethasone for the treatment of parthenium dermatitis: a randomized controlled study.

AbstractBACKGROUND:
Parthenium hysterophorus is the commonest cause of airborne contact dermatitis in India. Azathioprine has been shown to be effective and safe in parthenium dermatitis, but there are no reports of comparison of steroids and azathioprine in this condition.
AIMS:
To study the therapeutic efficacy of azathioprine versus betamethasone in patients having contact dermatitis to parthenium and compare the side effects of the drugs.
METHODS:
Fifty-five patients of airborne contact dermatitis to parthenium were randomly assigned to treatment with azathioprine 100 mg daily (group A) or betamethasone 2 mg daily (group B), for 6 months in a blinded manner. The patients were evaluated every month for 6 months to determine the response to treatment and side effects and then further followed up for another 6 months to determine any relapse.
RESULTS:
There were 26 patients in group A and 29 in group B, of which 20 patients of group A and 21 of group B completed the study. Nineteen (95%) patients in group A and all 21 (100%) patients in group B had an excellent response (complete remission) to treatment (P=0.0156 vs. 0.0005). The patients in group B, however, had more adverse effects (Fisher exact, P<or=0.05). Nine (45%) patients in group A and 14 (67%) patients in group B relapsed during the post-treatment follow-up.
CONCLUSIONS:
Azathioprine and betamethasone appear to be almost equally effective (P=0.0156 vs. 0.0005) in the treatment of parthenium dermatitis. However, adverse effects and relapses were observed to be more frequent in patients treated with betamethasone.
AuthorsKaushal K Verma, R Mahesh, Pushplata Srivastava, M Ramam, A K Mukhopadhyaya
JournalIndian journal of dermatology, venereology and leprology (Indian J Dermatol Venereol Leprol) 2008 Sep-Oct Vol. 74 Issue 5 Pg. 453-7 ISSN: 0973-3922 [Electronic] United States
PMID19052402 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Betamethasone
  • Azathioprine
Topics
  • Acne Vulgaris (chemically induced, pathology)
  • Adult
  • Aged
  • Azathioprine (adverse effects, therapeutic use)
  • Betamethasone (adverse effects, therapeutic use)
  • Dermatitis, Contact (drug therapy, pathology)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Treatment Outcome
  • Weight Gain (drug effects, physiology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: